hERG is expressed in numerous human cancer cell lines and tissues but is absent in corresponding healthy cells (Cherubini, et al., 2000; Lastraioli, et al., 2004; Pillozzi, et al., 2002), suggesting that it may confer a selective advantage to tumor cells. Here, KCNH2 is linked to cancer.